Company Monitoring Page for Shire

latest headlines for company on cafepharma

Shire's new Baxalta hemophilia meds drop the ball in first combined quarter
Fierce Pharma
Wed, 11/2/16 - 09:56 am
Tags:
Shire, Baxalta, hemophilia, earnings
Shire confident in hemophilia despite looming pricing challenge
BioPharma Dive
Tue, 11/1/16 - 04:55 pm
Tags:
Shire, hemophilia, drug pricing, PBMs
Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal
Endpoints
Tue, 10/25/16 - 09:54 am
Tags:
Shire, myelofibrosis, CTI BioPharma, Baxalta, M&A, pacritinib
AbbVie Is Under Duress With Fierce Competition
Seeking Alpha
Thu, 10/20/16 - 09:20 am
Tags:
AbbVie, Humira, biosimilars, Amgen, Baxalta, Shire
Shire wants consumers and their eyes to be 'Friends'
BioPharma Dive
Thu, 10/13/16 - 10:40 am
Tags:
Shire, celebrity endorsements, dry eye disease, Xiidra
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wed, 09/28/16 - 10:18 am
Tags:
Shire, biosimilars, Humira, Enbrel, Momenta
Shire wants out of that $172M Baxalta deal with CTI Bio
Endpoints
Mon, 09/19/16 - 06:03 pm
Tags:
Shire, Baxalta, CTI BioPharma, M&A
Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market
Medical Marketing and Media
Fri, 08/26/16 - 10:02 am
Tags:
Shire, dry eye disease, Xiidra, celebrity endorsements
GSK, Merck shares win as 2016 brings big moves. Losers? You know who
Fierce Pharma
Tue, 08/23/16 - 10:00 am
Tags:
GSK, Merck, Valeant Pharmaceuticals, Endo International, Sagent Pharmaceuticals, Alkermes, Shire, Perrigo
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Bidness, ETC
Fri, 08/19/16 - 11:50 am
Tags:
Shire, Raptor Pharmaceuticals, M&A, Retrophin, Rare Diseases
In the Spirit of the Olympics: On and Off the Pharma Podium
PharmExec
Sat, 08/13/16 - 06:44 pm
Tags:
Shire, Xiidra, Bayer, JNJ, beloranib, Zafgen, GSK, Valeant Pharmaceuticals
Shire launches new treatment for hereditary bleeding disorder
BioPharma Dive
Thu, 08/11/16 - 09:30 am
Tags:
Shire, drug launches, Vonvendi, von Willebrand disease
Elliott Associates sues AbbVie over failed bid for Shire
Yahoo/Reuters
Sat, 08/6/16 - 01:11 pm
Tags:
AbbVie, Shire, M&A
Shire cans Baxalta hemophilia B gene therapy, thinning field for uniQure, Spark
Fierce Biotech
Wed, 08/3/16 - 09:39 am
Tags:
Shire, Baxalta, hemophilia B, gene therapy, BAX 335, Spark Therapeutics, uniQure
Shire upgrades Baxalta cost savings after Q2 earnings beat
Yahoo/Reuters
Tue, 08/2/16 - 09:03 am
Tags:
Shire, Baxalta, earnings
The Shire Vs. Allergan War Has Begun
Seeking Alpha
Mon, 08/1/16 - 09:39 am
Tags:
Shire, Allergan, dry eye disease, Xiidra, Restasis
Shire targets Allergan's dry-eye market share by pricing Xiidra at $5K per year--right on par with Restasis
Fierce Pharma
Tue, 07/26/16 - 11:25 am
Tags:
dry eye disease, Shire, Allergan, Xiidra, Restasis
Shire bags a quick thumbs up for its newly won cancer drug pipeline
Endpoints
Mon, 07/25/16 - 11:15 am
Tags:
Shire, Baxalta, M&A, Onivyde
Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
Forbes
Mon, 07/25/16 - 09:51 am
Tags:
biotech, M&A, Pfizer, Teva Pharmaceutical, Allergan, Shire, Portola Pharmaceuticals, Sanofi, Medivation, Regeneron, Biogen
Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
TheStreet.com
Thu, 07/14/16 - 07:21 pm
Tags:
Shire, ADHD, Baxalta, Brexit, M&A, Vyvanse

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.